Biomarin Pharmaceutical Inc (BMRN) Insider Trading
- $1,316,196.75
- $342,139,664.94
- Nov. 12, 2024
- Jean Jacques Bienaime
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 20, 2020 | Insider | 17,213 | $90.00 | Sell | $1,549,170.00 | |
April 9, 2020 | CEO | 10,000 | $79.06 | Sell | $790,600.00 | |
April 8, 2020 | EVP | 2,407 | $79.98 | Sell | $192,511.86 | |
April 1, 2020 | EVP | 1,537 | $82.00 | Sell | $126,034.00 | |
March 24, 2020 | EVP | 2,041 | $74.36 | Sell | $151,768.76 | |
March 17, 2020 | Director | 3,750 | $75.39 | Sell | $282,712.50 | |
March 9, 2020 | CEO | 10,000 | $89.52 | Sell | $895,200.00 | |
Jan. 14, 2020 | CEO | 8,000 | $87.95 | Sell | $703,600.00 | |
Jan. 7, 2020 | CEO | 3,000 | $84.46 | Sell | $253,380.00 | |
Dec. 27, 2019 | CEO | 5,000 | $86.16 | Sell | $430,800.00 | |
Dec. 17, 2019 | Director | 3,750 | $83.36 | Sell | $312,600.00 | |
Nov. 26, 2019 | EVP | 3,190 | $79.66 | Sell | $254,115.40 | |
Nov. 22, 2019 | CEO | 10,000 | $77.60 | Sell | $776,000.00 | |
Oct. 25, 2019 | CEO | 5,000 | $69.55 | Sell | $347,750.00 | |
Sept. 17, 2019 | Director | 3,750 | $74.47 | Sell | $279,262.50 | |
June 17, 2019 | Director | 3,750 | $81.08 | Sell | $304,050.00 | |
May 10, 2019 | CEO | 10,000 | $82.52 | Sell | $825,200.00 | |
May 8, 2019 | CEO | 4,000 | $82.16 | Sell | $328,640.00 | |
April 26, 2019 | CEO | 3,000 | $82.88 | Sell | $248,640.00 | |
April 12, 2019 | CEO | 4,000 | $89.12 | Sell | $356,480.00 | |
April 8, 2019 | CEO | 3,000 | $91.87 | Sell | $275,610.00 | |
April 5, 2019 | CEO | 3,000 | $93.37 | Sell | $280,110.00 | |
April 5, 2019 | SVP | 2,953 | $94.00 | Sell | $277,582.00 | |
April 1, 2019 | CFO | 13,473 | $89.00 | Sell | $1,199,097.00 | |
March 27, 2019 | CFO | 100 | $90.00 | Sell | $9,000.00 | |
March 27, 2019 | Director | 2,150 | $89.76 | Sell | $192,984.00 | |
March 25, 2019 | EVP | 3,363 | $87.86 | Sell | $295,473.18 | |
March 25, 2019 | Insider | 5,932 | $87.86 | Sell | $521,185.52 | |
March 25, 2019 | CEO | 4,000 | $87.86 | Sell | $351,440.00 | |
March 21, 2019 | EVP | 4,519 | $89.98 | Sell | $406,619.62 | |
March 19, 2019 | EVP | 3,728 | $93.07 | Sell | $346,964.96 | |
March 18, 2019 | Insider | 9,597 | $94.09 | Sell | $902,981.73 | |
March 15, 2019 | CEO | 4,000 | $94.40 | Sell | $377,600.00 | |
March 12, 2019 | CEO | 9,000 | $90.06 | Sell | $810,540.00 | |
March 7, 2019 | CEO | 4,000 | $90.78 | Sell | $363,120.00 | |
March 4, 2019 | Insider | 2,196 | $95.00 | Sell | $208,620.00 | |
Feb. 27, 2019 | CEO | 4,000 | $91.78 | Sell | $367,120.00 | |
Feb. 21, 2019 | CEO | 3,000 | $90.12 | Sell | $270,360.00 | |
Feb. 14, 2019 | CEO | 4,000 | $95.20 | Sell | $380,800.00 | |
Feb. 5, 2019 | CEO | 4,000 | $98.63 | Sell | $394,520.00 | |
Jan. 22, 2019 | CEO | 3,000 | $96.82 | Sell | $290,460.00 | |
Jan. 14, 2019 | CEO | 4,000 | $93.79 | Sell | $375,160.00 | |
Jan. 10, 2019 | CEO | 3,000 | $90.55 | Sell | $271,650.00 | |
Jan. 7, 2019 | CEO | 3,000 | $87.58 | Sell | $262,740.00 | |
Dec. 28, 2018 | CEO | 3,000 | $84.04 | Sell | $252,120.00 | |
Dec. 28, 2018 | CEO | 3,000 | $84.04 | Sell | $252,120.00 | |
Dec. 27, 2018 | Director | 2,150 | $82.53 | Sell | $177,439.50 | |
Dec. 26, 2018 | CEO | 4,000 | $80.50 | Sell | $322,000.00 | |
Dec. 14, 2018 | CEO | 2,000 | $92.64 | Sell | $185,280.00 | |
Dec. 12, 2018 | CEO | 2,000 | $93.12 | Sell | $186,240.00 |
Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.
The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere
The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.
Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.
David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.
The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.
The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.
The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.